PSPro Enables Single-Cell-Type Spatial Proteomics in Complex
Single-Cell-Type Spatial Proteome Profiling with PSPro: Advances in Tissue Context Analysis
Study Background and Research Question
Multicellular tissues are composed of diverse cell types organized in a spatially intricate microenvironment, where cell–cell interactions drive both physiological and pathological functions. Deciphering the molecular architecture of these tissues at single-cell-type and spatial resolution is essential for understanding tissue function, disease progression, and therapeutic targeting. Historically, spatial proteomics has relied on two main strategies: laser microdissection coupled with mass spectrometry (LMD-MS), and antibody-based imaging platforms. While these methods have enabled region-specific or targeted protein mapping, each faces trade-offs among spatial resolution, throughput, and proteome coverage, limiting practical applicability in complex tissue settings. Mao et al. set out to overcome these limitations by developing a new workflow capable of simultaneous, cell-type-resolved spatial proteome profiling in single tissue slices (Mao et al., 2025).
Key Innovation from the Reference Study
The central innovation of the study is PSPro (Proximity-labeling for Spatial Proteomics), a method that integrates antibody-directed proximity biotinylation with efficient affinity purification. This workflow enables “all-at-once” enrichment of proteomes from multiple cell types, preserving their spatial context within a single tissue section. By optimizing labeling parameters, PSPro achieves sub-micrometer spatial selectivity alongside high proteome coverage, allowing thousands of proteins—including cell-type markers—to be identified and spatially mapped from complex tissues. Notably, PSPro can be seamlessly combined with laser microdissection to further resolve spatial heterogeneity within and between cell subpopulations.
Methods and Experimental Design Insights
PSPro employs an antibody-targeted proximity labeling approach. Tissue sections are first incubated with primary antibodies specific to cell-type markers. Secondary antibodies conjugated to an enzyme, typically horseradish peroxidase (HRP), are then applied. Upon addition of a biotin-tyramide substrate, HRP catalyzes the covalent deposition of biotin onto nearby proteins—a reaction known as horseradish peroxidase catalyzed tyramide deposition. This step spatially confines biotinylation to the immediate vicinity of the target antigen, allowing selective enrichment of cell-type-specific proteomes. After labeling, proteins are affinity-purified via streptavidin capture, subjected to on-bead digestion, and analyzed by quantitative mass spectrometry.
- Optimization experiments determined the ideal concentrations and incubation times for both antibody and tyramide substrate to maximize labeling specificity and proteome yield.
- To benchmark performance, PSPro was compared against conventional LMD-MS and flow cytometry-based proteomics using the same tissues.
- The workflow was validated in murine pancreatic tumor and spleen slices, chosen for their cellular diversity and relevance to tumor immunology.
- Integration with laser microdissection enabled further subdivision of tissue slices to examine intra-tissue spatial heterogeneity.
Protocol Parameters
- Antibody incubation: Optimize for specificity to target cell-type markers; typical incubation at 4°C overnight for primary antibody, 1 hour at room temperature for HRP-conjugated secondary antibody.
- Biotin-tyramide labeling: Use HRP substrate at empirically determined concentrations; incubation for 10–15 minutes at room temperature yields robust, spatially resolved biotinylation (as optimized in the reference study).
- Affinity purification: Streptavidin bead capture immediately following labeling, with extensive washing to reduce nonspecific binding.
- On-bead digestion: Standard trypsin protocols, optimized for low-input samples.
- Mass spectrometry: High-sensitivity LC-MS/MS, with attention to minimizing carryover between samples.
Core Findings and Why They Matter
Applying PSPro to tumor and spleen slices, Mao et al. achieved comprehensive spatial proteome maps for ten distinct cell types in a single tissue section. PSPro consistently enriched thousands of proteins, including canonical lineage markers, with minimal cross-labeling between cell types. Integration with laser microdissection revealed spatial heterogeneity among both cancer and immune cell populations within pancreatic tumor tissue. These findings underscore the method’s power for dissecting complex tissue microenvironments and mapping proteomic diversity at unprecedented resolution.
Crucially, PSPro overcomes several limitations inherent to prior platforms:
- It circumvents the low throughput and loss of spatial information associated with serial LMD-MS sampling.
- It achieves greater proteome coverage and cell-type selectivity than conventional antibody-based imaging, which is often limited by the number of available fluorophores or tags.
- Sub-micrometer resolution and high specificity allow robust detection of low-abundance targets within their native tissue context.
This level of granularity is essential for studies of tumor heterogeneity, immune infiltration, and tissue remodeling—key areas in cancer biology and regenerative medicine.
Comparison with Existing Internal Articles
The advances demonstrated by PSPro directly intersect with ongoing developments in signal amplification for immunohistochemistry and fluorescent labeling for in situ hybridization workflows. Several internal articles elaborate on these themes:
- Amplifying Discovery in Cancer Metabolism discusses the translational significance of high-sensitivity tyramide signal amplification, including strategic deployment of the Cy5 TSA Fluorescence System Kit, for detecting low-abundance metabolic targets in cancer tissues. The PSPro workflow extends these efforts by enabling proteome-wide, spatially resolved analysis across diverse cell types in a single experiment.
- Spatial Proteome Profiling at Single-Cell-Type Resolution by PSPro provides a detailed summary of Mao et al., reinforcing how PSPro's all-at-once strategy resolves throughput and coverage trade-offs in spatial proteomics.
- For practical guidance on maximizing the sensitivity and reproducibility of cell-based fluorescence assays, Optimizing Low-Abundance Target Detection with Cy5 TSA Fluorescence System Kit supplies Q&A-driven troubleshooting and method optimization, complementing the technical focus of PSPro.
Together, these resources situate PSPro within the broader context of evolving proteomic and fluorescence-based spatial profiling technologies, highlighting the critical role of signal amplification and precise labeling chemistries in advancing tissue-level discovery.
Limitations and Transferability
Despite its strengths, PSPro faces several limitations. The method relies on high-quality, cell-type-specific antibodies for successful proximity labeling, which may not be available for all targets or tissues. There is also a need for careful optimization of labeling conditions to minimize off-target biotinylation and maximize proteome yield. While the method achieves high spatial resolution, its reliance on tissue sectioning and antibody penetration imposes practical constraints on sample thickness and tissue types. Transferability to human clinical samples or highly fibrotic tissues may require additional protocol adjustments.
Moreover, while the combination with LMD enables intra-tissue comparisons, the overall throughput is still influenced by downstream mass spectrometry capacity and data analysis pipelines. Researchers should consider these factors when applying PSPro to large-scale studies or highly heterogeneous tissues.
Research Support Resources
For researchers aiming to implement proximity proteomics or optimize immunocytochemistry fluorescence enhancement and signal amplification for in situ hybridization, reliable labeling and detection reagents are critical. The Cy5 Tyramide Signal Amplification (TSA) Fluorescence System Kit (SKU: K1052) from APExBIO offers a robust platform for horseradish peroxidase catalyzed tyramide deposition, enabling rapid, high-sensitivity fluorescent labeling suitable for both discovery and validation workflows. This kit is particularly useful for detecting low-abundance proteins in tissue sections, as described in the product information. Integration of such tools with proximity proteomics protocols like PSPro can further advance spatially resolved, quantitative molecular profiling in complex biological systems.